PAG
IBIO icon

Private Advisor Group’s iBio IBIO Stock Holding History

Private Advisor Group’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-36
Closed -$3K – 1797
2022
Q3 		$3K Sell
36
-25
-41% -$3.44K ﹤0.01% 1904
2022
Q2 		$8K Sell
61
-23
-27% -$3.46K ﹤0.01% 2097
2022
Q1 		$18K Buy
84
+21
+33% +$4.39K ﹤0.01% 2072
2021
Q4 		$17K Buy
63
+30
+91% +$11.4K ﹤0.01% 2113
2021
Q3 		$18K Sell
33
-2
-6% -$1.25K ﹤0.01% 1999
2021
Q2 		$26K Buy
35
+5
+17% +$3.65K ﹤0.01% 1954
2021
Q1 		$23K Buy
+30
New +$26.1K ﹤0.01% 1868
2020
Q3 		– Sell
-8
Closed -$9K – 2446
2020
Q2 		$9K Buy
+8
New +$5.23K ﹤0.01% 2977

Other funds holding IBIO

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Private Advisor Group's IBIO Position: Q4 2022 in Review

Private Advisor Group sold out of iBio (IBIO) in Q4 2022, closing a stake of 36 shares — an estimated $3K sold.

Private Advisor Group first reported a position in IBIO in Q2 2020 and held it in 8 quarters. The position peaked at $26K in Q2 2021. 36 funds tracked by Wall St. Rank hold IBIO as of Q4 2022.

  • Private Advisor Group reported no remaining iBio position as of Q4 2022 after selling out during the quarter.
  • Private Advisor Group sold 36 iBio shares in Q4 2022, an estimated $3K.
  • Private Advisor Group first reported a position in iBio in Q2 2020 and held it in 8 quarters.
  • Private Advisor Group's iBio position peaked at $26K in Q2 2021.
  • 36 funds tracked by Wall St. Rank held iBio as of Q4 2022.

Based on Private Advisor Group's 13F filing for Q4 2022, filed 18 Jan 2023.